載入...
Infliximab dose adjustment can improve the clinical and radiographic outcomes of rheumatoid arthritis patients: REVIVE study results
PURPOSE: We evaluated the clinical responses and radiographic outcomes of 90 patients with rheumatoid arthritis (RA) undergoing continuous or dose-adjusted infliximab treatment over 104 weeks. PATIENTS AND METHODS: Patients received 3 mg/kg infliximab continuously (the contin group; n=50), or the do...
Na minha lista:
| 發表在: | Biologics |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6267494/ https://ncbi.nlm.nih.gov/pubmed/30568425 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S187998 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|